Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P Langdon

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
Metabolites|February 15, 2018
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation ResponsivenessCarol Ward, James Meehan, Mark Gray, et al.
Current Topics in Microbiology and Immunology|March 13, 2019
Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and TreatmentCarol Ward, James Meehan, Mark Gray, et al.
Endocrine-Related Cancer|December 3, 2005
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogenAmanda J M O'Donnell, Kenneth G Macleod, David J Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroupAngela Bowman, Hani Gabra, Simon P Langdon, et al.
Plos One|December 19, 2015
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel BiomarkersRomina Briffa, Inhwa Um, Dana Faratian, et al.
Gynecologic Oncology|July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
Oncotarget|December 20, 2015
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancerRui Huang, Simon P Langdon, Matthew Tse, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyDana Faratian, Inhwa Um, Danielle S Wilson, et al.
Metabolites|February 15, 2018
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation ResponsivenessCarol Ward, James Meehan, Mark Gray, et al.
Current Topics in Microbiology and Immunology|March 13, 2019
Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and TreatmentCarol Ward, James Meehan, Mark Gray, et al.
Endocrine-Related Cancer|December 3, 2005
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogenAmanda J M O'Donnell, Kenneth G Macleod, David J Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroupAngela Bowman, Hani Gabra, Simon P Langdon, et al.
Plos One|December 19, 2015
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel BiomarkersRomina Briffa, Inhwa Um, Dana Faratian, et al.
Gynecologic Oncology|July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Biochemical Society Transactions|August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancerCarlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Experimental and Molecular Pathology|July 3, 2024
FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgroundsSarah J Taylor, Robert L Hollis, Charlie Gourley, et al.
Oncotarget|December 20, 2015
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancerRui Huang, Simon P Langdon, Matthew Tse, et al.
Pageof 9